Ewing sarcoma is the second most commonly diagnosed form of primary bone cancer in children and young adults - 2020 marks 100 years since the disease was first discovered by James Ewing. On June 12th we will be holding our first ever Ewing Sarcoma Symposium - our first dedicated event bringing together the international Ewing sarcoma research community to strategise future research investment.

The day will be led by Professor Sue Burchill BSc (HONS),MD, PhD. Professor Burchill is the Professor of Cancer Research at the University of Leeds and Scientific director of the Children’s Cancer Research Group at St James’s University Hospital, which is a translational research programme she established in 1992. Her primary research interests in the metastatic drug resistant disease have led her to become the chair of the Society International of Oncology Paediatric-Neuroblastoma (SIOPEN) who run clinical trials, the European Ewing’s Consortium (EEC) who monitor molecular biological studies, and is the co-chair of the International Neuroblastoma Response Criteria (INRC) Bone Marrow Working Group who lead international circulating biomarker studies for children with neuroblastoma.

If you are from the research community and would like to attend the symposium, please email the Bone Cancer Research Trust's Head of Research, Information & Support, Dr Zoe Davison.


Free drinks and refreshments will be available at the symposium for all guests.

Venue details

Village Hotel, Centennial Park, 210 Centennial Ave, Elstree, Borehamwood WD6 3SJ

Free parking is available on site for all guests.